These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1709545)

  • 21. Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease.
    Cunningham-Rundles C; Siegal FP; Smithwick EM; Lion-Boulé A; Cunningham-Rundles S; O'Malley J; Barandun S; Good RA
    Ann Intern Med; 1984 Oct; 101(4):435-9. PubMed ID: 6206756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect on the safety of intravenous immunoglobulin of testing plasma for antibody to hepatitis C.
    Biswas RM; Nedjar S; Wilson LT; Mitchell FD; Snoy PJ; Finlayson JS; Tankersley DL
    Transfusion; 1994 Feb; 34(2):100-4. PubMed ID: 7508642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group.
    Locasciulli A; Testa M; Valsecchi MG; Bacigalupo A; Solinas S; Tomas JF; Ljungman P; Alberti A
    Transplantation; 1999 Nov; 68(10):1486-91. PubMed ID: 10589944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.
    Newburger JW; Takahashi M; Beiser AS; Burns JC; Bastian J; Chung KJ; Colan SD; Duffy CE; Fulton DR; Glode MP
    N Engl J Med; 1991 Jun; 324(23):1633-9. PubMed ID: 1709446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of antibodies to hepatitis C virus in a long-term prospective study of posttransfusion hepatitis among thalassemic children: comparison between first- and second-generation assay.
    Lai ME; De Virgilis S; Argiolu F; Farci P; Mazzoleni AP; Lisci V; Rapicetta M; Clemente MG; Nurchis P; Arnone M
    J Pediatr Gastroenterol Nutr; 1993 May; 16(4):458-64. PubMed ID: 7686220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immune serum globulin in immunodeficiency.
    Cunningham-Rundles C
    Vox Sang; 1985; 49 Suppl 1():8-14. PubMed ID: 2416128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on the efficacy of prophylactic gamma globulin in infectious hepatitis in institutions for children].
    Eichhorn D; Dietzsch HJ
    Dtsch Gesundheitsw; 1966 Aug; 21(34):1599-604. PubMed ID: 4162732
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and histological features of sporadic non-A, non-B hepatitis.
    Hyodo I; Yamada G; Nishihara T; Okushin H; Kinoyama S; Sakamoto Y; Tobe K; Nagashima H
    Acta Med Okayama; 1984 Aug; 38(4):389-401. PubMed ID: 6437147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous gamma globulin in the management of patients with hypogammaglobulinemia.
    Magilavy DB; Cassidy JT; Tubergen DG; Petty RE; Chrisholm R; McCall K
    J Allergy Clin Immunol; 1978 Jun; 61(6):378-83. PubMed ID: 77867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum alpha-fetoprotein levels in acute viral hepatitis.
    Kew MC; Purves LR; Bersohn I
    Gut; 1973 Dec; 14(12):939-42. PubMed ID: 4131854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier state.
    Feinman SV; Berris B; Cooter N; Sinclair JC; Wrobel DM
    Hepatogastroenterology; 1982 Apr; 29(2):58-61. PubMed ID: 7084885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components. International Factor Safety Study Group.
    Shapiro A; Abe T; Aledort LM; Anderle K; Hilgartner MW; Kunschak M; Preston FE; Rivard GE; Schimpf K
    Transfusion; 1995 Mar; 35(3):204-8. PubMed ID: 7878711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency.
    Björkander J; Cunningham-Rundles C; Lundin P; Olsson R; Söderström R; Hanson LA
    Am J Med; 1988 Jan; 84(1):107-11. PubMed ID: 3122562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From the Centers for Disease Control and Prevention. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    JAMA; 1994 Aug; 272(6):424-5. PubMed ID: 8040966
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravenous gamma-globulin: clinical applications in pediatric care.
    Ott MJ; Senner A; Esker S; Knapp R; Bolinger AM
    J Pediatr Nurs; 1990 Oct; 5(5):307-15. PubMed ID: 1698963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemistry and safety of native intravenous gammaglobulin (IGIV, pH 4.25).
    Schwartz RS
    J Clin Apher; 1988; 4(2-3):89-92. PubMed ID: 2456285
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics, Safety, and Tolerability of Subcutaneous Immune Globulin Injection (Human), 10 % Caprylate/Chromatography Purified (GAMUNEX®-C) in Pediatric Patients with Primary Immunodeficiency Disease.
    Heimall J; Chen J; Church JA; Griffin R; Melamed I; Kleiner GI
    J Clin Immunol; 2016 Aug; 36(6):600-9. PubMed ID: 27342758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipid-enveloped and non-lipid-enveloped viruses. The Ad Hoc Study Group of the Fondazione dell'Emofilia.
    Mariani G; Di Paolantonio T; Baklaya R; Morfini M; Mannucci PM
    Transfusion; 1993 Oct; 33(10):814-8. PubMed ID: 8236421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in immunoglobulin preparations for intravenous use: a comparison of six products.
    Greenbaum BH
    Am J Pediatr Hematol Oncol; 1990; 12(4):490-6. PubMed ID: 1704686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.